Last Updated: 06/06/2026

Hammersmith Medicines Research

London

Founded 1993

UK's largest early-phase clinical CRO specialising in first-in-human trials

Hammersmith Medicines Research is one of the largest early-phase contract research organisations in Europe, specialising in Phase I and early Phase II clinical trials of investigational medicinal products.

Operating from a purpose-built 145-bed facility in West London, HMR provides fully integrated services from study design through to clinical study report.

The unit holds MHRA Phase I accreditation and licences for controlled drugs, radiolabelled compounds, and investigational medicinal products.

CRO Clinical Research Drug Discovery

Clinical Trial Site Patient Recruitment Pharmacovigilance

Is this your company?

Claim this page to receive a verified badge and keep your profile up to date.

Claim page

Company Notes

AKA / Aliases

HMR; HMR London

Similar Companies

Pharmagene Discovery Services

Cambridge

Analytical Services International

London

Pebble Bio

Manchester